Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications in the Publications section are now described as automatically filled from PubMed, and the Revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe funding-status disclaimer was removed from the page, potentially reducing visibility of data timeliness for the study record.SummaryDifference0.3%

- Check34 days agoChange DetectedResults data for primary and secondary outcomes with time points are now displayed. Updated study completion dates and the list of participating sites are also reflected.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check69 days agoChange DetectedPage update includes a new version tag (v3.1.0) and removal of several MedlinePlus topics and an older version tag (v3.0.2).SummaryDifference0.4%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No changes to core content, pricing, stock availability, or time slot availability.SummaryDifference0.2%

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.